Here’s Why We’re A Bit Worried About Moleculin Biotech’s (NASDAQ:MBRX) Cash Burn Situation

Here's Why We're A Bit Worried About Moleculin Biotech's (NASDAQ:MBRX) Cash Burn SituationWe can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made…

from Yahoo Finance https://ift.tt/3gOmPTo

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *